蛋白质稳态
生物
泛素连接酶
蛋白酶体
转录组
泛素
免疫疗法
细胞生物学
T细胞
细胞毒性T细胞
功能(生物学)
癌症研究
细胞
癌症免疫疗法
免疫学
泛素蛋白连接酶类
细胞分化
免疫系统
细胞周期
癌症
损失函数
淋巴细胞
DNA损伤
细胞生长
T淋巴细胞
基因剔除小鼠
蛋白质组
人口
作者
Nicole E. Scharping,Xuezhen Ge,Maria I. Matias,Fulin Jiang,Allison Cafferata,Maximilian Heeg,Alexander Troy Monell,Giovanni Galletti,Kitty Cheung,Angelica Rock,Nick Thao,Sydnye L. Shuttleworth,Michael Bauer,Kennidy K. Takehara,Amir Ferry,Sara Quon,Brian Koss,Samuel Myers,Eric J. Bennett,Ananda W. Goldrath
出处
期刊:
[Cold Spring Harbor Laboratory]
日期:2026-02-10
被引量:1
标识
DOI:10.64898/2026.02.08.704716
摘要
Summary Tumor-infiltrating lymphocytes (TIL) often fail to restrain tumor growth due to progressive differentiation to an ‘exhausted’ state. In healthy tissues, tissue-resident memory T cells (T RM ) maintain protection for years, and patient tumors that contain TIL with T RM features are associated with better prognosis. Proteomic and transcriptomic profiling of T cell populations identified proteostasis as a significant factor distinguishing T RM and progenitor-exhausted TIL from terminally-exhausted TIL, including loss of E3 ubiquitin ligases NEURL3, RNF149, and WSB1, with accumulation of unfolded proteins in spite of functional proteasome activity. Enforced expression of these ligases by TIL preserved stem-like TCF1 + populations and improved anti-tumor function, whereas their knockout impaired TIL and altered T cell differentiation in acute infection. Sustained ligase expression rescued accumulation of unfolded proteins in TIL and improved immunotherapy outcome in preclinical models, highlighting the critical role of proteostasis in TIL function and identifying new avenues for advancing cancer immunotherapy.
科研通智能强力驱动
Strongly Powered by AbleSci AI